244 related articles for article (PubMed ID: 26472023)
1. Mitotic entry: Non-genetic heterogeneity exposes the requirement for Plk1.
Aspinall CF; Zheleva D; Tighe A; Taylor SS
Oncotarget; 2015 Nov; 6(34):36472-88. PubMed ID: 26472023
[TBL] [Abstract][Full Text] [Related]
2. Polo-like kinase 1 inhibitor BI2536 causes mitotic catastrophe following activation of the spindle assembly checkpoint in non-small cell lung cancer cells.
Choi M; Kim W; Cheon MG; Lee CW; Kim JE
Cancer Lett; 2015 Feb; 357(2):591-601. PubMed ID: 25524551
[TBL] [Abstract][Full Text] [Related]
3. Preferential Killing of Tetraploid Colon Cancer Cells by Targeting the Mitotic Kinase PLK1.
Jemaà M; Kifagi C; Serrano SS; Massoumi R
Cell Physiol Biochem; 2020 Apr; 54(2):303-320. PubMed ID: 32259417
[TBL] [Abstract][Full Text] [Related]
4. The small-molecule inhibitor BI 2536 reveals novel insights into mitotic roles of polo-like kinase 1.
Lénárt P; Petronczki M; Steegmaier M; Di Fiore B; Lipp JJ; Hoffmann M; Rettig WJ; Kraut N; Peters JM
Curr Biol; 2007 Feb; 17(4):304-15. PubMed ID: 17291761
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic polo-like kinase 1 inhibition results in mitotic arrest and subsequent cell death of blasts in the bone marrow of AML patients and has similar effects in non-neoplastic cell lines.
Münch C; Dragoi D; Frey AV; Thurig K; Lübbert M; Wäsch R; Bogatyreva L; Hauschke D; Lassmann S; Werner M; May AM
Leuk Res; 2015 Apr; 39(4):462-70. PubMed ID: 25697066
[TBL] [Abstract][Full Text] [Related]
6. Differential Cellular Effects of Plk1 Inhibitors Targeting the ATP-binding Domain or Polo-box Domain.
Shin SB; Woo SU; Yim H
J Cell Physiol; 2015 Dec; 230(12):3057-67. PubMed ID: 25975351
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of polo-like kinase 1 leads to the suppression of osteosarcoma cell growth in vitro and in vivo.
Liu X; Choy E; Harmon D; Yang S; Yang C; Mankin H; Hornicek FJ; Duan Z
Anticancer Drugs; 2011 Jun; 22(5):444-53. PubMed ID: 21399492
[TBL] [Abstract][Full Text] [Related]
8. Plk1 inhibition causes post-mitotic DNA damage and senescence in a range of human tumor cell lines.
Driscoll DL; Chakravarty A; Bowman D; Shinde V; Lasky K; Shi J; Vos T; Stringer B; Amidon B; D'Amore N; Hyer ML
PLoS One; 2014; 9(11):e111060. PubMed ID: 25365521
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Plk1 induces mitotic infidelity and embryonic growth defects in developing zebrafish embryos.
Jeong K; Jeong JY; Lee HO; Choi E; Lee H
Dev Biol; 2010 Sep; 345(1):34-48. PubMed ID: 20553902
[TBL] [Abstract][Full Text] [Related]
10. Co-inhibition of polo-like kinase 1 and Aurora kinases promotes mitotic catastrophe.
Li J; Hong MJ; Chow JP; Man WY; Mak JP; Ma HT; Poon RY
Oncotarget; 2015 Apr; 6(11):9327-40. PubMed ID: 25871386
[TBL] [Abstract][Full Text] [Related]
11. Polo-like kinase 1 is essential for the first mitotic division in the mouse embryo.
Baran V; Solc P; Kovarikova V; Rehak P; Sutovsky P
Mol Reprod Dev; 2013 Jul; 80(7):522-34. PubMed ID: 23649868
[TBL] [Abstract][Full Text] [Related]
12. Use of the novel Plk1 inhibitor ZK-thiazolidinone to elucidate functions of Plk1 in early and late stages of mitosis.
Santamaria A; Neef R; Eberspächer U; Eis K; Husemann M; Mumberg D; Prechtl S; Schulze V; Siemeister G; Wortmann L; Barr FA; Nigg EA
Mol Biol Cell; 2007 Oct; 18(10):4024-36. PubMed ID: 17671160
[TBL] [Abstract][Full Text] [Related]
13. Impact of Polo-like kinase 1 inhibitors on human adipose tissue-derived mesenchymal stem cells.
Ritter A; Friemel A; Kreis NN; Louwen F; Yuan J
Oncotarget; 2016 Dec; 7(51):84271-84285. PubMed ID: 27713178
[TBL] [Abstract][Full Text] [Related]
14. The responses of cancer cells to PLK1 inhibitors reveal a novel protective role for p53 in maintaining centrosome separation.
Smith L; Farzan R; Ali S; Buluwela L; Saurin AT; Meek DW
Sci Rep; 2017 Nov; 7(1):16115. PubMed ID: 29170437
[TBL] [Abstract][Full Text] [Related]
15. Stathmin and microtubules regulate mitotic entry in HeLa cells by controlling activation of both Aurora kinase A and Plk1.
Silva VC; Cassimeris L
Mol Biol Cell; 2013 Dec; 24(24):3819-31. PubMed ID: 24152729
[TBL] [Abstract][Full Text] [Related]
16. PLK1 inhibitors: setting the mitotic death trap.
Plyte S; Musacchio A
Curr Biol; 2007 Apr; 17(8):R280-3. PubMed ID: 17437704
[TBL] [Abstract][Full Text] [Related]
17. Designed inhibitor for nuclear localization signal of polo-like kinase 1 induces mitotic arrest.
Chen F; Zhuo X; Qin T; Guo X; Zhang C; Lai L
Chem Biol Drug Des; 2017 May; 89(5):732-740. PubMed ID: 27882722
[TBL] [Abstract][Full Text] [Related]
18. Optimized Plk1 PBD Inhibitors Based on Poloxin Induce Mitotic Arrest and Apoptosis in Tumor Cells.
Scharow A; Raab M; Saxena K; Sreeramulu S; Kudlinzki D; Gande S; Dötsch C; Kurunci-Csacsko E; Klaeger S; Kuster B; Schwalbe H; Strebhardt K; Berg T
ACS Chem Biol; 2015 Nov; 10(11):2570-9. PubMed ID: 26279064
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Polo-like kinase 1 by DNA damage in mitosis. Inhibition of mitotic PLK-1 by protein phosphatase 2A.
Jang YJ; Ji JH; Choi YC; Ryu CJ; Ko SY
J Biol Chem; 2007 Jan; 282(4):2473-82. PubMed ID: 17121863
[TBL] [Abstract][Full Text] [Related]
20. Targeted inhibition of Polo-like kinase 1 by a novel small-molecule inhibitor induces mitotic catastrophe and apoptosis in human bladder cancer cells.
Zhang Z; Zhang G; Kong C
J Cell Mol Med; 2017 Apr; 21(4):758-767. PubMed ID: 27878946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
